Research background
Retatrutide is a single-chain synthetic peptide reported to engage three incretin-family receptors, making it a frequent reference compound in triple-agonist structure-activity work. Because the glucagon receptor arm distinguishes it from dual agonists, it is often used in energy-expenditure rather than purely intake-focused models.


